http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
신종익,이정한,송한범,강대언,오상훈,차승렬,이용재,김상대,이원호 대한건축학회 2004 대한건축학회 학술발표대회 논문집 - 계획계/구조계 Vol.24 No.1(구조계)
This study investigates the performance of the reinforced concrete frame with the steel plate slit damper. The test was carried out to investigate the structural behavior between the reinforced concrete bare frame and the reinforced concrete frame with the steel plate slit damper. The test results showed that the energy absorption capacity of the damped-frame was several times larger than that of the bare frame. For the damage by the input energy is concentrated on the steel plate slit damper, the ductilities of the former structure were increased and the damaged frame can be reused after exchange the steel plate slit damper.
( Beom Kyung Kim ),( Do Young Kim ),( Hye Jin Choi ),( Seung-hoon Beom ),( Hye Won Lee ),( Seung Up Kim ),( Jun Yong Park ),( Sang Hoon Ahn ),( Jinsil Seong ),( Kwang-hyub Han ) 대한간학회 2017 춘·추계 학술대회 (KASL) Vol.2017 No.1
Aims: Patients with advanced hepatocellular carcinoma (HCC) have a particularly poor prognosis of the median overall survival of less than 12 months. Even though sorafenib has been approved for treating advanced stage HCC, the unsatisfactory objective response rate still remain unresolved. In the current study, we aimed to evaluate the efficacy and safety of localized concurrent chemoradiotherapy (CCRT) followed by sequential sorafenib treatment for advanced hepatocellular carcinoma. Methods: This study is an ongoing, phase II trial. Patients with advanced HCC not amenable for curative treatments were eligible. In the course of radiotherapy for 5 weeks, hepatic arterial infusion of 5-fluorouracil (500mg/day) via implanted port was applied during the first 5 days and the last 5 days of radiotherapy. Four weeks after localized CCRT, sorafenib (400mg bid) was maintained. The pri mary endpoint was overall survival. Results: A total of 47 patients were enrolled. After the completion of localized CCRT, the objective response rate was 31.9%. During the overall treatment course, the objective response rate was 46.8% respectively. Overall, 7 patients (14.9%) underwent curative resection or transplantation after down-staging. The median overall survival was 18.4 months and the progression-free survival was 6.8 months. Adverse events were predictable and manageable with conservative care. Conclusions: Localized CCRT followed by sequential sorafenib treatment in patients with advanced HCC showed significant activity and good tolerability. Furthermore, such a treatment modality, when compared to the use of sorafenib alone, might provide the additional therapeutic benefit through initial tumor reduction, allowing curative treatment after down-staging in 14.9% of patients, Further randomized trial should be required to make the more robust evidence.
Anti-inflammatory activity of Camellia japonica oil
( Seung Beom Kim ),( Eun Sun Jung ),( Seung Woo Shin ),( Moo Han Kim ),( Young Soo Kim ),( Jong Sung Lee ),( Deok Hoon Park ) 생화학분자생물학회 (구 한국생화학분자생물학회) 2012 BMB Reports Vol.45 No.3
Camellia japonica oil (CJ oil) has been used traditionally in East Asia to nourish and soothe the skin as well as help restore the elasticity of skin. CJ oil has also been used on all types of bleeding instances. However, little is known about its anti-inflammatory effects. Therefore, the anti-inflammatory effects of CJ oil and its mechanisms of action were investigated. CJ oil inhibited LPS-induced production of NO, PGE2, and TNF-α in RAW264.7 cells. In addition, expression of COX-2 and iNOS genes was reduced. To evaluate the mechanism of the anti-inflammatory activity of CJ oil, LPS-induced activation of AP-1 and NF-κB promoters was found to be significantly reduced by CJ oil. LPS-induced phosphorylation of IκBα, ERK, p38, and JNK was also attenuated. Our results indicate that CJ oil exerts anti-inflammatory effects by downregulating the expression of iNOS and COX-2 genes through inhibition of NF-κB and AP-1 signaling. [BMB reports 2012; 45(3): 177-182]
Seung Hoon Yoo,Byung Jun Min,Kum Bae Kim,Sungho Cho,Eun Ho Kim,Jeong Hoon Park,Won-Gyun Jung,Geun Beom Kim,Seung Young Ko,Hyun Soo Shin,Sei Kyung Chang,Ho Jin Jeong,Dong Ho Shin,Kwan Ho Cho 한국물리학회 2016 THE JOURNAL OF THE KOREAN PHYSICAL SOCIETY Vol.69 No.12
The aim of the present study was to find the optimum dynamic conformal arc (DCA)-based radiosurgery conditions for treatment of patients with intracranial tumors. DCA plans were generated on a commercial treatment-planning system (BrainSCAN v.5.31) for various beam-number and gantry-angle combinations by using computed tomography (CT) scans to delineate the planning target volume (PTV) and the organs at risk (OARs). To evaluate planning quality related to the various planning conditions, we analyzed the dose quality factors (DQFs) for 22 patients as a function of the number and the total angle of arcs related to the target volume, which were determined on the basis of patient-specific features. When the total angle of arcs was less than 250, the DQF values were under 0.98 (worst group). When the total angle of arcs was more than 350 degrees, the DQF values were maximized, and the highest DQF values (best group, DQF > 0.995) occurred in the range between 50 and 120/cm3 for the total angle/target volume condition. In this optimal range of angle/volume, the asymmetric distribution of the arcs resulted in decreased DQF values. For a relatively large target volume (more than 10 cm3), the DQF values were lower than these for a relatively small target volume (less than 10 cm3). Re-planning results showed that the planning quality could be improved using optimized planning conditions. We expect that this study will provide a basis for the evaluation of various DCA conditions prior to actual planning and treatment.
항행 및 항법 : A-SMGCS 구현을 위한 위험요소 식별에 대한 연구
홍승범 ( Seung Beom Hong ),최승훈 ( Seung Hoon Choi ),최연철 ( Youn Chul Choi ) 한국항행학회 2015 韓國航行學會論文誌 Vol.19 No.1
최근 국내에서 A-SMGCS (advance surface movement ground control systems) 레벨 Ⅳ 단계를 구현하기 위한 연구가 활발히 진행중에 있다. 전체 A-SMGCS 시스템의 안전을 확보하기 위하여 안전성 평가가 필요하며, 유로컨트롤에서는 A-SMGCS의 안전성 평가를 위하여 기능별 위험요소 평가, 예비시스템 안전성 평가, 그리고 시스템 안전성 평가를 수행하도록 권고하고 있다. 본 논문에서는 기능별 위험요소 평가 방법을 통하여 전체 A-SGMCS의 위험요소를 식별한다. 따라서 A-SMGCS레벨 Ⅳ 시스템에 대하여 29가지 위험 요소를 식별하고 각 위험요소의 심각도를 평가하는 자료로 활용할 것이다. Recently, it is actively under study for the implementation of advance surface movement ground control systems (A-SMGCS) level Ⅳ in Korea. To ensure the safety of the A-SMGCS system needs the safety assessment, and Eurocontrol is encouraged to perform the functional hazard assessment, preliminary system safety assessment, and system safety assessment to the safety assessment of A-SMGCS. In this paper, we identify the hazard of A-SMGCS through a functional hazard assessment. Therefore, we will identify 29 types of hazard for the A-SMGCS level Ⅳ and serve as important data to evaluate the severity of each hazard.
Wine drinking and epithelial ovarian cancer risk: a meta-analysis.
Kim, Hee Seung,Kim, Jae Weon,Shouten, Leo J,Larsson, Susanna C,Chung, Hyun Hoon,Kim, Yong Beom,Ju, Woong,Park, Noh Hyun,Song, Yong Sang,Kim, Seung Cheol,Kang, Soon-Beom Korean society of gynecologic oncology and colposc 2010 Journal of Gynecologic Oncology Vol.21 No.2
<P>Wine has been the focus in the prevention of epithelial ovarian cancer (EOC) development because resveratrol abundant in wine has anti-carcinogenic properties. However, epidemiologic results have been heterogenous in the chemopreventive effect of wine on the development of EOC. Thus, we performed a meta-analysis for comparing EOC risk between wine and never drinkers using previous related studies.</P>
Sim, Sung Hoon,Beom, Seung‐,Hoon,Ahn, Yong‐,Oon,Keam, Bhumsuk,Kim, Tae Min,Lee, Se‐,Hoon,Kim, Dong‐,Wan,Heo, Dae Seog Wiley-Blackwells 2016 Thoracic cancer Vol.7 No.2
<P><B>Abstract</B></P><P><B>Background</B></P><P>The neutrophil‐lymphocyte ratio (NLR) is a marker of poor prognosis in lung cancer patients. However, previous data have been based on an heterogeneous population of lung cancer patients and various treatments. In this study, we evaluate the prognostic value of NLR in an homogeneous population of epidermal growth factor receptor (EGFR)‐mutant non‐small cell lung cancer (NSCLC) patients.</P><P><B>Methods</B></P><P>We restrospectively evaluated the data of 250 NSCLC patients with EGFR mutations. All data are based on first‐line treatment.</P><P><B>Results</B></P><P>All tumors harbored in‐frame deletions in exon 19 or an L858R point mutation. Eighty‐five patients were treated with tyrosine kinase inhibitors (TKIs), while 165 received cytotoxic chemotherapy as first‐line treatment. Multivariate survival analysis revealed that the NLR was a significant prognostic factor for first‐line progression‐free survival (PFS) in the chemotherapy group (hazard ratio [HR] 1.882, 95% confidence interval [CI] 1.319–2.686, <I>P</I> = 0.001), but was not significant in the TKI group (HR 1.239, 95% CI 0.693–2.215, <I>P</I> = 0.469). The response rate (RR) to first‐line treatment was 76.5% in the TKI group and 29.5% in the chemotherapy group; however, the RR, according to the NLR (≤3 vs. > 3), was the same for both groups.</P><P><B>Conclusions</B></P><P>The NLR was a significant prognostic factor in the chemotherapy group, but it did not affect either RR or PFS in EGFR‐mutant NSCLC patients treated with TKIs.</P>
Impact of Liver Fibrosis on Long-Term Outcome in Ischemic Stroke Patients
( Seung Up Kim ),( Minyoul Baik ),( Sungwoo Kang ),( Hyung Jong Park ),( Hyo Suk Nam ),( Ji Hoe Heo ),( Beom Kyung Kim ),( Jun Yong Park ),( Do Young Kim ),( Sang Hoon Ahn ),( Kwang-hyub Han ),( Young 대한간학회 2018 춘·추계 학술대회 (KASL) Vol.2018 No.1
Aims: To investigate whether there are differences in long-term all-cause and cardiovascular mortality by the burden of liver fibrosis or steatosis in patients with ischemic stroke or transient ischemic attack (TIA). Methods: Consecutive patients with acute ischemic stroke or TIA, who underwent transient elastography (TE) from January 2014 to December 2014, were considered eligible. The influence of liver fibrosis or steatosis, assessed using TE, on long-term outcomes was investigated using Cox proportional hazard models. Results: Among 395 patients included in this study, there were 37 (9%) patients with significant fibrosis (>8.0 kPa) and 164 (41.5%) patients with fatty liver (>250 dB/m). During the follow-up (median 2.7 years), all-cause and cardiovascular mortality occurred in 28 (7.1%) and 20 (5.1%) patients. On multivariate analyses, significant liver fibrosis was independently associated with increased risk of all-cause (HR 8.14, 95% CI 3.03-21.90, P< 0.001) and cardiovascular (HR 4.04, 95% CI 1.17-13.98, P=0.028) mortality, whereas fatty liver was not (all > p 0.05) Conclusions: This study demonstrated that the burden of liver fibrosis, not steatosis assessed on TE was an independent predictor of all-cause and cardiovascular mortality during long-term follow-up in patient with ischemic stroke.
( Seung Hwan Shin ),( Seung Up Kim ),( Jun Yong Park ),( Do Young Kim ),( Sang Hoon Ahn ),( Kwang Hyub Han ),( Beom Kyung Kim ) 대한간학회 2013 춘·추계 학술대회 (KASL) Vol.2013 No.1
Background: Liver stiffness is a reliable, noninvasive marker assessing not only the degree of fibrosis but also development of hepatocellular carcinoma and hepatic decompensation. Recently, LSM-based prediction model, LSM-spleen diameter to platelet ratio score (LSPS = LSM × spleen diameter/platelet count) proved to be well correlated with development of portal hypertension-related cirrhotic complications. Here, we assessed the prognostic value of LSPS for development of HCC in patients with chronic hepatitis B virus (HBV) infection during long-term follow-up. Methods: We retrospectively analyzed 227 patients with chronic HBV infection who had well-preserved liver function, and no history of prior decompensation or HCC from 2006 to 2008. The major end point was diagnosis of HCC, examined using Kaplan-Meier and Cox regression method. Results: The median age was 45 years and 156 (68.7%) were male. During follow-up (median 61 months), 18 patients were diagnosed as HCC. Patient with HCC had the higher LS values and spleen size, and the lower platelet counts (all P<0.05). When patients were stratified into three groups (LSPS <1.1, 1.1-2.5 and ≥ 2.5), the 5-year cumulative risk of HCC development significantly increased in association with the higher LSPS value (4.0%, 13.8%, 36.2%, respectively, P<0.001). From multivariate analysis, patients with LSPS 1.1-2.5 [hazard ratio (HR) 3.782, P=0.039] and patients with LSPS ≥ 2.5 [HR 12.460, P<0.001] were at a great HCC development compared to patients with LSPS <1.1. Conclusions: LSPS is also useful in risk assessment of developing HCC among patients with chronic HBV infection. Effort to early detect HCC and careful regular follow up are needed for patients with LSPS > 1.1.
Cerebral Microbleeds: Their Associated Factors, Radiologic Findings, and Clinical Implications
Beom Joon Kim,Seung-Hoon Lee 대한뇌졸중학회 2013 Journal of stroke Vol.15 No.3
Cerebral microbleeds (CMBs) are tiny, round dark-signal lesions that are most often detected on gradient-echo MR images. CMBs consist of extravasations of blood components through fragile microvascular walls characterized by lipohyalinosis and surrounding macrophages. The prevalence of CMBs in elderly subjects with no history of cerebrovascular disease is around 5%, but is much higher in patients with ischemic or hemorrhagic stroke. Development of CMBs is closely related to various vascular risk factors; in particular, lobar CMBs are thought to be associated with cerebral amyloid angiopathy. The presence of CMBs has been hypothesized to reflect cerebral-hemorrhage-prone status in patients with hypertension or amyloid microangiopathy. Stroke survivors with CMBs have been consistently found to have an elevated risk of subsequent hemorrhagic stroke or an antithrombotic-related hemorrhagic complication, although studies have failed to establish a link between CMBs and hemorrhagic transformation after thrombolytic treatment. A large prospective study is required to clarify the clinical significance of CMBs and their utility in a decision-making index.